Yutao Guo

ORCID: 0000-0002-7626-7751
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Acute Ischemic Stroke Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Antiplatelet Therapy and Cardiovascular Diseases
  • ECG Monitoring and Analysis
  • Cardiac electrophysiology and arrhythmias
  • COVID-19 Clinical Research Studies
  • Cardiac Health and Mental Health
  • Healthcare Systems and Public Health
  • Cardiac pacing and defibrillation studies
  • Blood Pressure and Hypertension Studies
  • Acute Myocardial Infarction Research
  • COVID-19 and healthcare impacts
  • Heart Rate Variability and Autonomic Control
  • Mobile Health and mHealth Applications
  • Obstructive Sleep Apnea Research
  • Cardiovascular and Diving-Related Complications
  • Telemedicine and Telehealth Implementation
  • Multi-Agent Systems and Negotiation
  • Pharmaceutical Economics and Policy
  • Heart Failure Treatment and Management
  • Cardiac Imaging and Diagnostics
  • Research in Cotton Cultivation

Chinese PLA General Hospital
2016-2025

Tsinghua University
2025

Shantou Central Hospital
2012-2025

Liverpool Heart and Chest Hospital
2020-2024

University of Liverpool
2020-2024

State Key Laboratory of Cotton Biology
2018-2024

Liverpool John Moores University
2022-2024

Henan University
2018-2024

Chinese People's Liberation Army
2023

Tianjin Medical University
2023

Recent case-series of small size implied a pathophysiological association between coronavirus disease 2019 (COVID-19) and severe large-vessel acute ischemic stroke. Given that strokes are typically associated with poor prognosis can be very efficiently treated recanalization techniques, confirmation this putative is urgently warranted in large representative patient cohort to alert stroke clinicians, inform pre- in-hospital pathways. We pooled all consecutive patients hospitalized...

10.1161/strokeaha.120.031208 article EN Stroke 2020-07-09

BackgroundMobile Health technology for the management of patients with atrial fibrillation is unknown.MethodsThe simple mobile AF (mAF) App was designed to incorporate clinical decision-support tools (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age ≥75 years, Diabetes Mellitus, Prior Stroke or TIA, Vascular disease, 65–74 Sex category], HAS-BLED [Hypertension, Abnormal renal/liver function, Stroke, Bleeding history predisposition, Labile INR, Elderly, Drugs/alcohol concomitantly],...

10.1016/j.amjmed.2017.07.003 article EN cc-by-nc-nd The American Journal of Medicine 2017-08-26

Abstract Aims Cardiovascular diseases (CVDs) increase mortality risk from coronavirus infection (COVID-19). There are also concerns that the pandemic has affected supply and demand of acute cardiovascular care. We estimated excess in specific CVDs, both ‘direct’, through infection, ‘indirect’, changes healthcare. Methods results used (i) national data for England Wales to investigate trends non-COVID-19 CVD deaths; (ii) routine hospitals (n = 2), Italy 1), China 5) assess indirect effects on...

10.1093/eurjpc/zwaa155 article EN cc-by-nc European Journal of Preventive Cardiology 2021-01-01

Atrial fibrillation (AF) is highly prevalent with a lifetime risk of about 1 in 3–5 individuals after the age 45 years. Between 2010 and 2019, global prevalence AF has risen markedly from 33.5 million to 59 living AF. Early detection implementation appropriate treatment could reduce frequency complications associated International management guidelines recommend opportunistic systematic screening for AF, but additional data are needed. Digital approaches pathways have been proposed early...

10.1016/j.lanepe.2023.100786 article EN cc-by-nc-nd The Lancet Regional Health - Europe 2024-02-01

Background The Mobile Health (mHealth) Technology for Improved Screening and Optimized Integrated Care in atrial fibrillation (AF) (mAFA-II) cluster randomized trial assessed the efficacy of an integrated care approach improving prognosis AF patients. In this study, we provide a reanalysis outcomes using win ratio (WR) approach. Methods mAFA-II allocated patients to receive mHealth-technology implemented Atrial Fibrillation Better (ABC) pathway (mAFA intervention) or usual care. primary...

10.1055/s-0043-1769612 article EN Thrombosis and Haemostasis 2023-05-29

The discharge of Fukushima radioactively contaminated water into the Pacific Ocean started in August 2023, posing comprehensive threats to marine ecosystems and human health globally. This study introduces Contaminated Water Risk Factor (FCWRF), which integrates three components─radionuclide diffusion, bioaccumulation, global seafood trade─to evaluate spatiotemporal distribution risks based on actual practices. Results suggest that exceeding 2 orders magnitude beyond baseline will be...

10.1021/acs.est.4c08145 article EN cc-by-nc-nd Environmental Science & Technology 2025-02-12
Coming Soon ...